Profile

Blood glucose monitoring, multi-year subdermal implant.

Dermal Therapy Research Inc., in collaboration with scientists at the Karolinska Institute, Sweden, has developed a multi-year (possibly lifetime) subdermal implanted device to monitor blood glucose levels via a smartphone, eliminating the need for onboard power, batteries, reagents, or optics. Each measurement takes seconds, making this device suitable for a single test or CGM, as reported in Nature’s Scientific Reports.

It is seeking a partner for regulatory testing, registration and commercialization.

Dermal Therapy Research Inc. logo

Website

dermaltherapy.com

Contact


Event details

Date: October 5 - 8, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

14 in total